What Cayceo does

Cayceo (SAS CAYCEO) is a Montpellier-based French company that develops IPNEO, a Class 1 certified medical device combining immersive virtual reality software with a library of clinical-grade hypnotic sessions for non-pharmacological anxiety and pain management. The platform pairs custom VR environments (Le Bois aux lanternes, Au-delà du Lagon, La Galerie des glaces, La Tête dans les nuages) with a tactile control solution that allows a single caregiver to pilot one or multiple VR headsets. Sessions are co-developed internally by 3D artists applying video game and animation cinema techniques in conjunction with a multidisciplinary medical board anchored by clinical psychologist Jean-Michel Marty and Professor Antoine Bioy of Université Paris 8.

The company monetises IPNEO through direct institutional sales to French hospitals, university hospital centres (CHU), private clinics, and cancer institutes under a subscription or annual licensing model with no public pricing; quotes are provided on a consultative basis via a contact form. Distribution is dual-channel: direct institutional sales supplemented by listing on UGAP, the French public procurement agency, which allows public healthcare institutions to procure through official frameworks. The customer base includes major French CHUs (Bordeaux, Toulouse, Lyon, Nîmes, AP-HP Bicêtre and Necker), the ICM Unicancer cancer centre, and private groups such as Elsan Care and Clinique Bonnefon. The firm operates with a 1–10 person headcount from an atelier inside the Halle Tropisme innovation campus in Montpellier.

In 2023, Cayceo was acquired by Lumeen, a strategic acquirer in the therapeutic VR space, with the stated intent of building the most comprehensive therapeutic VR solution on the market. Following the acquisition, the Cayceo brand and product continue to operate as a portfolio entity under Lumeen, with clinical research partnerships and session-library expansion used both as validation mechanisms and as the primary commercial funnel within the French healthcare market.

Name

Cayceo

Legal name

SAS CAYCEO

Website

https://cayceo.fr

Company type

Private

Founded year

2017

Operating status

Acquired

Headcount range

1–10 employees

Short description

Cayceo develops IPNEO, a Class 1 certified medical VR device delivering immersive hypnotic sessions for non-pharmacological anxiety and pain management, sold to French hospitals, clinics, and cancer institutes.

Ownership category

akta.pro rank

Product category

Medical Virtual Reality Therapy

NAICS

Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Primary Care & General Medicine Virtual Care (HLALAAAA)

Keywords

• Medical virtual reality
• Digital therapeutics devices
• VR pain management
• Clinical hypnosis software
• Hospital anxiety treatment

Headquarters

HQ city

Montpellier

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. IPNEO Medical Device Licensing/Subscription: IPNEO is sold as a Class 1 medical device combining VR software (hypnotic session library) and hardware piloting solution. Revenue is likely generated through device and software licensing, possibly subscription-based given the recurring nature of session updates and library evolution. The solution is offered to healthcare institutions ( CHU, clinics, cancer institutes) who purchase or lease the system for use across patient care pathways.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Cayceo develops and sells IPNEO, a Class 1 certified medical device combining VR software and a library of medically validated hypnotic sessions with a tactile piloting solution for single or multiple VR headsets. The system provides non-pharmacological anxiolytic and analgesic treatment for patients undergoing medical procedures, and is sold to hospitals, clinics, and cancer institutes across France.

Product overview

Cayceo offers IPNEO, a certified Class 1 medical device that is the first complete turnkey solution for medical hypnosis in virtual reality. The product combines VR software with a library of hypnotic sessions designed for specific clinical indications in anxiety and pain management. The portfolio includes four distinct session types: Le Bois aux lanternes (hypno-relaxation), Au-delà du Lagon (hypno-relaxation), La Galerie des glaces (hypnoanalgesia), and La tête dans les nuages (hypno-sedation), each adaptable in duration to match the care procedure rather than the reverse. The sessions are developed by 3D artists and clinical practitioners, with a multidisciplinary medical board overseeing the production. Cayceo was acquired by Lumeen with the goal of offering the most comprehensive therapeutic VR solution on the market.

Differentiator

Problem solved

Functional benefit

Brands

• IPNEO: First complete turnkey medical virtual reality hypnosis solution indicated for anxiety and pain management throughout the patient care pathway. Class 1 medical device combining VR software with hypnotic session library and tactile piloting hardware solution for single or multiple VR headsets.

Products and services

• IPNEO IPNEO is a Class 1 certified medical device combining VR software and a library of hypnotic sessions for anxiolytic and analgesic purposes. It includes a tactile piloting solution for single or multi-VR headset configurations, enabling a single caregiver to manage multiple patients simultaneously. The system provides non-pharmacological hypnosis therapy for patients managing anxiety and pain throughout their care journey, used by hospitals, clinics, and cancer institutes in France.

Quantifiable outcome

• 98% of healthcare professionals recommend the sessions (study of 50 professionals, CFHTB 2019)
• +2 more outcomes

Named customers11 records

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core and minor.

• LumeencoreOthers · 1 January 2022Cayceo was acquired by Lumeen, with the stated promise of offering the most comprehensive therapeutic VR solution on the market. Lumeen subsequently acquired Cayceo to expand its portfolio in therapeutic virtual reality, combining Cayceo's medical hypnosis VR expertise with Lumeen's broader VR offerings.
• IPNOSIA (Institut de Recherche en Hypnose Médicale)coreStrategic or Co-development Partner · 1 January 2019IPNOSIA is co-led by Pr Antoine Bioy (responsible scientist for IPNOSIA, Professor at Paris 8, UNESCO scientific advisor, and President of the 'Humanisation des soins' commission at Fondation de France). IPNOSIA provides scientific oversight and clinical validation for Cayceo's IPNEO sessions, contributing to the medical board that governs session development.
• UGAPminorChannel Partner/ Reseller/ DistributorUGAP (Union des Groupements d'Achats Publics) is the French public procurement agency. Cayceo's IPNEO solution is listed on UGAP, allowing French public healthcare institutions to purchase the solution through official government procurement frameworks.
• Université Paris 8 Vincennes-Saint-DenisminorStrategic or Co-development PartnerUniversité Paris 8, where Pr Antoine Bioy serves as Professor, is listed as a trusted partner. The university connection provides academic and scientific credibility to Cayceo's IPNEO solution through the involvement of its faculty in the medical board.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Regional players

• Psious: Spain-based VR platform for mental health professionals with similar anxiety-management use cases, primarily serving Iberian and Latin American markets.

Broad incumbents

• Samsung Health (Samsung Electronics): Major VR hardware OEM exploring health and wellness applications. Competes indirectly by enabling third-party medical VR on consumer-grade headsets, lowering barriers for non-specialized alternatives.
• MindMaze: Larger neuro/VR health platform with FDA/CE cleared products across rehab and cognition. Broad incumbent operating across multiple therapeutic VR verticals.
• Meta (Reality Labs Health): Owns Quest VR headsets used in many healthcare VR pilots. Indirect but significant competitor via partnerships with hospital systems and third-party medical VR software developers.

Direct peers

• Oncomfort: Belgium-based medical VR for pain and anxiety management in hospitals. Comparable Class I/IIa certified digital therapeutic device with overlapping indications and European clinical focus.
• AppliedVR: US therapeutic VR platform FDA-authorized for chronic pain, with deployments across US health systems. Direct peer in VR-based non-pharmacological pain/anxiety therapy for clinical use.
• XRHealth: VR therapy platform operating clinics and reimbursement-backed programs for pain, anxiety, and rehabilitation. Comparable model of clinically validated VR interventions sold to providers.
• BehaVR: US therapeutic VR company building evidence-based VR programs for mental health, chronic pain, and oncology. Overlapping patient populations and clinical evidence-led positioning.
• HypnoVR: French medical hypnosis VR platform used for anesthesia, analgesia, and anxiety. Closest direct competitor — same therapeutic modality, same clinical use cases, and same French GTM motion.
• Lumeen: Parent company and operator of a therapeutic VR platform for healthcare and eldercare. Directly comparable product category (therapeutic VR in care settings) and overlapping institutional customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/_Cayceo
• Facebookfacebook.com/CayceoVR
• LinkedInlinkedin.com/company/cayceo
• Instagraminstagram.com/cayceo_dev

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cayceo